December 4, 2024

Higher Medicine Received a Letter of Intent (LOI) for the Seed Investment

From Montreal-based Desire Ventures, led by Dr. Assad Aslam, an acclaimed toxicologist and biotech investor, contingent upon a matching investor participating in the round. The proceed from the investment will fund IND-enabling pre-clinical research for the lead p38 inhibitor program for Friedreich's Ataxia.

Latest News

Our platform offers a variety of resources to keep you informed about our latest programs, key updates, achievements, and other significant developments in the field of healthcare and medicine.

Company Announcements
April 25, 2025

Higher Medicine Selected for HiveBio Accelerator Cohort

HiveBio Accelerator program offers world-class training, mentorship, and support to help scale Higher Medicine and secure follow-on funding.

Read more